Skip to content

Effects of sub-anesthetic dose of esketamine on early postoperative cognitive function and analgesia in elderly patients with laparoscopic gastrointestinal surgery

Effects of sub-anesthetic dose of esketamine on early postoperative cognitive function and analgesia in elderly patients with laparoscopic gastrointestinal surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064720
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early postoperative cognitive function and analgesia

Interventions

Experimental group:Anesthesia induction is pre-given at a sub-anesthetic dose of esketamine

Sponsors

Quanzhou First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. The patient is classified as I, II, and III according to the American Society of Anesthesiologists (ASA) anesthesia classification; 2. Patients aged 60-79 years old; 3. Not allergic to the drugs used in this study; 4. Those who plan to undergo laparoscopic gastrointestinal surgery.

Exclusion criteria

Exclusion criteria: 1. Those who have contraindications to general anesthesia or have had a history of anesthesia accidents in the past; 2. Severe abnormalities in cardiac function: acute heart failure, unstable angina, myocardial infarction within 6 months prior to screening, resting electrocardiogram heart rate=2.5 × ULNTBIL>=1.5 × ULN 6. Renal dysfunction: Urea nitrogen>=1.5 × ULN, blood creatinine greater than the upper limit of normal value; 7. History of alcoholism and drug abuse within one year, i.e. drinking more than 2 units of alcohol per day (1 unit=360 mL beer or 150 mL wine or 45 mL Baijiu with 40% alcohol); 8. Take opioid analgesics every day or intermittently for the past three months within a month; 9. Those who are allergic or contraindicated to propofol, opioid analgesics, and their drug components; 10. Have participated in any clinical trial as a subject within the past year; 11. The subject explicitly refused to participate in this study; 12. The researchers believe that patients should not participate in this trial.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Blood sugar;

Countries

China

Contacts

Public ContactXie Wenqin

Quanzhou First Hospital

xiewenqin9@126.com+86 13599269966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026